Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1992 2
1994 3
1995 2
1996 6
1997 5
1998 3
1999 5
2000 12
2001 8
2002 3
2003 8
2004 8
2005 5
2006 12
2007 19
2008 18
2009 18
2010 17
2011 21
2012 21
2013 26
2014 22
2015 15
2016 22
2017 17
2018 19
2019 22
2020 51
2021 31
2022 30
2023 42
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

462 results

Results by year

Filters applied: . Clear all
Page 1
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms.
Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Salvatori S, et al. Among authors: monteleone g. Int J Mol Sci. 2023 Feb 2;24(3):2895. doi: 10.3390/ijms24032895. Int J Mol Sci. 2023. PMID: 36769214 Free PMC article. Review.
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV Jr, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ; SEAVUE Study Group. Sands BE, et al. Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2. Lancet. 2022. PMID: 35691323 Clinical Trial.
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Clinical Trial.
Ultrasonographic Transmural Healing in Crohn's Disease.
Zorzi F, Rubin DT, Cleveland NK, Monteleone G, Calabrese E. Zorzi F, et al. Among authors: monteleone g. Am J Gastroenterol. 2023 Jun 1;118(6):961-969. doi: 10.14309/ajg.0000000000002265. Epub 2023 Mar 28. Am J Gastroenterol. 2023. PMID: 36988302 Review.
Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative Colitis.
Dinallo V, Marafini I, Di Fusco D, Laudisi F, Franzè E, Di Grazia A, Figliuzzi MM, Caprioli F, Stolfi C, Monteleone I, Monteleone G. Dinallo V, et al. Among authors: monteleone g. J Crohns Colitis. 2019 May 27;13(6):772-784. doi: 10.1093/ecco-jcc/jjy215. J Crohns Colitis. 2019. PMID: 30715224
Reply.
Calabrese E, Zorzi F, Monteleone G. Calabrese E, et al. Among authors: monteleone g. Clin Gastroenterol Hepatol. 2022 Feb;20(2):473-474. doi: 10.1016/j.cgh.2021.05.007. Epub 2021 May 6. Clin Gastroenterol Hepatol. 2022. PMID: 33965579 No abstract available.
462 results